Microbiology Quiz: Cell Wall Synthesis Inhibitors
20 questions · exam conditions
0:00
Cell Wall Synthesis InhibitorsQuestion 1 of 20

Telavancin, a lipoglycopeptide antibiotic, exhibits enhanced bactericidal activity compared to vancomycin. This is due to a dual mechanism of action. What is the second mechanism, in addition to the inhibition of peptidoglycan polymerization that it shares with vancomycin?

Inhibition of DNA gyrase, preventing DNA replication.
Binding to the 30S ribosomal subunit to block protein synthesis.
Anchoring in the cell membrane, causing depolarization and increased permeability.
Covalent modification of penicillin-binding proteins to prevent cell wall cross-linking.
← Back to quizzes

Microbiology Quiz

Microbiology Quiz: Cell Wall Synthesis Inhibitors

Practice Cell Wall Synthesis Inhibitors in Microbiology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Cell Wall Synthesis Inhibitors, giving you a quick way to practice the rules, question types, and explanations that matter most for Microbiology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

Telavancin, a lipoglycopeptide antibiotic, exhibits enhanced bactericidal activity compared to vancomycin. This is due to a dual mechanism of action. What is the second mechanism, in addition to the inhibition of peptidoglycan polymerization that it shares with vancomycin?

  1. Inhibition of DNA gyrase, preventing DNA replication.
  2. Binding to the 30S ribosomal subunit to block protein synthesis.
  3. Anchoring in the cell membrane, causing depolarization and increased permeability. (correct answer)
  4. Covalent modification of penicillin-binding proteins to prevent cell wall cross-linking.
Explanation: Telavancin is a derivative of vancomycin that contains a lipid tail. This lipophilic moiety allows the drug to anchor into the bacterial cytoplasmic membrane. This anchoring disrupts the membrane's structure and leads to rapid depolarization of the membrane potential and increased permeability. This membrane-damaging effect is the second mechanism of action, which contributes to its potent, rapid bactericidal activity, complementing its primary action of inhibiting cell wall synthesis via D-Ala-D-Ala binding.

Question 2

Fosfomycin is a broad-spectrum antibiotic that acts very early in the peptidoglycan synthesis pathway. It functions as an analog of phosphoenolpyruvate (PEP) and irreversibly inactivates the enzyme MurA. This action directly prevents which biochemical reaction?

  1. The transfer of N-acetylmuramic acid to the bactoprenol lipid carrier.
  2. The addition of the pentapeptide chain to UDP-NAM.
  3. The conversion of UDP-NAG to UDP-NAM.
  4. The transfer of an enolpyruvyl group to UDP-N-acetylglucosamine. (correct answer)
Explanation: Fosfomycin inhibits the enzyme UDP-N-acetylglucosamine enolpyruvyl transferase (MurA). This enzyme catalyzes the first committed step in peptidoglycan biosynthesis: the transfer of an enolpyruvyl group from phosphoenolpyruvate (PEP) to the 3'-hydroxyl group of UDP-N-acetylglucosamine (UDP-NAG). This reaction forms UDP-N-acetylglucosamine-enolpyruvate, which is subsequently reduced to form UDP-N-acetylmuramic acid (UDP-NAM). By blocking this initial step, fosfomycin halts the entire downstream pathway.

Question 3

A methicillin-sensitive Staphylococcus aureus (MSSA) strain acquires the mecA gene, located on the staphylococcal cassette chromosome mec (SCCmec), becoming a methicillin-resistant S. aureus (MRSA) strain.

The protein product of the mecA gene, PBP2a, confers broad beta-lactam resistance through which mechanism?

  1. Functioning as a substitute transpeptidase with low binding affinity for beta-lactam antibiotics. (correct answer)
  2. Acting as a powerful beta-lactamase enzyme that hydrolyzes and inactivates the antibiotics.
  3. Altering the peptidoglycan precursor from D-Ala-D-Ala to D-Ala-D-Lactate to prevent drug binding.
  4. Serving as a transcriptional repressor that prevents the expression of native penicillin-binding proteins.
Explanation: The mecA gene encodes Penicillin-Binding Protein 2a (PBP2a). PBP2a is a transpeptidase that, due to its altered active site structure, has a very low affinity for nearly all beta-lactam antibiotics. It can continue to catalyze the essential cross-linking of the cell wall even when the bacterium's other native PBPs are inactivated by the drug. Beta-lactamase production and alteration of the precursor terminus are distinct resistance mechanisms seen in other bacteria.

Question 4

Imagine a hypothetical bacterium that possesses two key resistance features: 1) its transpeptidases are structurally altered, making them insensitive to beta-lactam binding, and 2) its peptidoglycan precursors terminate in D-alanyl-D-lactate instead of D-alanyl-D-alanine.

Which of the following cell wall synthesis inhibitors would most likely retain its activity against this highly resistant organism?

  1. Vancomycin
  2. Oxacillin
  3. Ceftaroline
  4. Bacitracin (correct answer)
Explanation: The insensitive transpeptidases confer resistance to all beta-lactams, including oxacillin and ceftaroline. The D-Ala-D-Lactate terminus confers resistance to glycopeptides like vancomycin, which cannot bind effectively. Bacitracin, however, acts on an entirely different and earlier step: it inhibits the dephosphorylation of the lipid carrier bactoprenol pyrophosphate. This process is essential for transporting peptidoglycan precursors across the membrane and is unaffected by the two resistance mechanisms described, so bacitracin would likely still be effective.

Question 5

In an in vitro cell wall synthesis assay, purified lipid-linked precursors (lipid II), a growing glycan acceptor chain, and bacterial enzymes are combined. The addition of an antibiotic is observed to halt the elongation of the glycan chain.

Which antibiotic most likely caused this effect by sterically hindering the transglycosylase enzyme from adding new disaccharide units to the polymer?

  1. Penicillin G
  2. Bacitracin
  3. Vancomycin (correct answer)
  4. Ceftriaxone
Explanation: Vancomycin binds to the D-Ala-D-Ala terminus of the lipid II precursor. This large molecule then acts as a steric shield, physically blocking the active sites of both the transglycosylase (which elongates the glycan chain) and the transpeptidase (which cross-links the peptides). Penicillin and ceftriaxone only inhibit the transpeptidase. Bacitracin would prevent the formation or transport of the lipid II precursor itself, an earlier step not described in the assay's outcome.

Question 6

The monobactam antibiotic aztreonam has an unusual spectrum of activity, targeting aerobic Gram-negative bacteria while having virtually no effect on Gram-positive bacteria or anaerobes. This high degree of specificity is primarily due to its:

  1. preferential and high-affinity binding to penicillin-binding protein 3 (PBP3) of aerobic Gram-negatives. (correct answer)
  2. inability to be recognized by the efflux pumps common in Gram-positive bacteria and anaerobes.
  3. exclusive use of a porin channel type that is absent in Gram-positive bacteria and anaerobes.
  4. requirement for activation by an oxidative metabolic process present only in aerobic bacteria.
Explanation: Aztreonam's narrow spectrum is a direct result of its target specificity. It binds with very high affinity to penicillin-binding protein 3 (PBP3) of aerobic Gram-negative rods (like Enterobacteriaceae and P. aeruginosa). PBP3 is essential for cell septum formation during division. Aztreonam has poor affinity for the PBPs of Gram-positive bacteria and anaerobic bacteria, rendering it ineffective against them. While entry via porins is necessary, the defining feature is its selective interaction with a specific PBP.

Question 7

Cycloserine is a second-line antitubercular agent that acts as a structural analog of D-alanine. Its bacteriostatic effect results from the competitive inhibition of which pair of enzymes crucial for peptidoglycan synthesis?

  1. Transpeptidase and transglycosylase
  2. InhA and KasA
  3. Alanine racemase and D-alanyl-D-alanine synthetase (correct answer)
  4. MurA and MurB transferases
Explanation: Cycloserine mimics the structure of D-alanine. It competitively inhibits two essential cytoplasmic enzymes: alanine racemase, which converts L-alanine to D-alanine, and D-alanyl-D-alanine synthetase (or ligase), which joins two D-alanine molecules to form the dipeptide needed for the pentapeptide chain. This starves the cell of the necessary D-Ala-D-Ala precursor. InhA and KasA are involved in mycolic acid synthesis (isoniazid targets). Transpeptidase and transglycosylase are later, periplasmic targets. MurA/B are earlier cytoplasmic steps not involving D-alanine.

Question 8

A physician is treating an Enterococcus faecalis infection with ampicillin, a beta-lactam. To improve bactericidal activity, a second agent is added. Which of the following agents would create a synergistic effect by inhibiting a preceding, sequential step within the same peptidoglycan synthesis pathway?

  1. Gentamicin
  2. Fosfomycin (correct answer)
  3. Daptomycin
  4. Clindamycin
Explanation: The question specifies synergy by inhibiting a sequential step in the same pathway. Ampicillin inhibits the final transpeptidation step of peptidoglycan synthesis. Fosfomycin inhibits MurA, which catalyzes the very first committed step of peptidoglycan synthesis in the cytoplasm. Therefore, it targets a preceding, sequential step. While gentamicin is famously synergistic with beta-lactams against enterococci, its mechanism is inhibition of protein synthesis, and the synergy arises because the cell-wall-active agent facilitates gentamicin's entry to the ribosome, not because they target sequential steps in one pathway.

Question 9

A researcher engineers a strain of Enterococcus faecium to constitutively express and secrete a D-Ala-D-Ala dipeptidase enzyme into its periplasmic space. This enzyme cleaves the terminal D-alanine from peptidoglycan precursors.

This genetic modification would be expected to confer the highest level of resistance to which of the following antibiotics?

  1. Daptomycin
  2. Penicillin
  3. Linezolid
  4. Vancomycin (correct answer)
Explanation: Vancomycin's mechanism of action is the specific binding to the D-Ala-D-Ala terminus of the NAM-pentapeptide precursor. The periplasmic dipeptidase would cleave this terminus, effectively removing the binding site for vancomycin and preventing its action. Penicillin binds to the transpeptidase enzyme, not the precursor, so its target remains. Daptomycin targets the cell membrane, and linezolid targets the ribosome; neither would be affected by this modification.

Question 10

Ethambutol is a key component of multi-drug therapy for tuberculosis. Its mechanism of action involves the specific inhibition of an enzyme complex responsible for which process in mycobacterial cell wall construction?

  1. The synthesis of long-chain mycolic acids.
  2. The transpeptidation of the peptidoglycan layer.
  3. The polymerization of arabinan into arabinogalactan. (correct answer)
  4. The transport of peptidoglycan precursors across the cell membrane.
Explanation: Ethambutol inhibits the mycobacterial arabinosyl transferases encoded by the embAB genes. These enzymes are essential for the polymerization of D-arabinofuranose residues into the arabinan domains of both arabinogalactan (AG) and lipoarabinomannan (LAM). Disruption of AG synthesis prevents the attachment of the outer mycolic acid layer to the peptidoglycan, compromising the entire cell wall structure. Mycolic acid synthesis is inhibited by isoniazid.

Question 11

A patient with atypical pneumonia caused by Mycoplasma pneumoniae is not responding to treatment with ceftriaxone. What is the fundamental microbiological basis for the ineffectiveness of ceftriaxone against this organism?

  1. The organism lacks a peptidoglycan cell wall. (correct answer)
  2. The organism rapidly effluxes the antibiotic across its cell membrane.
  3. The organism possesses penicillin-binding proteins with very low affinity for cephalosporins.
  4. The organism produces a chromosomal beta-lactamase that hydrolyzes ceftriaxone.
Explanation: Mycoplasma species are intrinsically resistant to all cell wall synthesis inhibitors, including beta-lactams like ceftriaxone, because they do not have a peptidoglycan cell wall. The drug's target is absent in the organism. The other options describe valid resistance mechanisms in other bacteria but are not the reason for the intrinsic resistance of Mycoplasma.

Question 12

Vancomycin demonstrates excellent activity against many Gram-positive pathogens like Staphylococcus aureus and Enterococcus faecalis, but it is ineffective against most Gram-negative organisms such as Pseudomonas aeruginosa. This limitation in its spectrum of activity is primarily a consequence of:

  1. the absence of D-Ala-D-Ala termini in the peptidoglycan of Gram-negative bacteria.
  2. the physical inability of the large vancomycin molecule to penetrate the Gram-negative outer membrane. (correct answer)
  3. the presence of specific periplasmic enzymes in Gram-negatives that rapidly degrade vancomycin.
  4. the expression of high-efficiency efflux pumps that expel vancomycin from the periplasm.
Explanation: Vancomycin is a large glycopeptide molecule with a molecular weight of approximately 1450 Da. The outer membrane of Gram-negative bacteria contains porin channels that typically restrict passage to smaller, hydrophilic molecules (usually < 600 Da). Vancomycin is too large to pass through these porins to reach its target, the D-Ala-D-Ala of peptidoglycan precursors located in the periplasmic space. This physical barrier is the principal reason for the intrinsic resistance of most Gram-negative bacteria.

Question 13

A population of Bacillus subtilis is treated with lysozyme in a hypertonic buffer, resulting in the formation of osmotically stable protoplasts. These protoplasts are then washed and resuspended in a fresh hypertonic medium containing a high concentration of penicillin.

What is the most probable fate of these protoplasts when incubated in the penicillin-containing medium?

  1. They will lyse immediately due to penicillin's effect on membrane integrity.
  2. They will remain viable because penicillin's target is absent. (correct answer)
  3. They will rapidly synthesize a new cell wall that is resistant to penicillin.
  4. They will be unable to divide but will slowly die from metabolic disruption.
Explanation: Protoplasts are bacterial cells from which the cell wall has been completely removed. Penicillin acts by inhibiting enzymes involved in peptidoglycan synthesis. Since protoplasts lack a cell wall and are not actively synthesizing one (especially in a resting state), penicillin has no target. As long as the external medium is osmotically stable (hypertonic) to prevent lysis, the protoplasts will remain viable and unaffected by the presence of penicillin.

Question 14

The efficacy of the beta-lactam antibiotic class relies on the strained beta-lactam ring, which functions as a structural mimic of a key component in the cell wall synthesis pathway. This mimicry allows the antibiotic to bind and inactivate transpeptidases. What component is being mimicked?

  1. The N-acetylmuramic acid sugar moiety
  2. The bactoprenol phosphate lipid carrier
  3. The D-alanyl-D-alanine peptide terminus (correct answer)
  4. The pentaglycine interpeptide bridge
Explanation: The beta-lactam ring is a structural analog of the D-alanyl-D-alanine terminus of the peptidoglycan pentapeptide. The transpeptidase (penicillin-binding protein) active site recognizes this structure and attempts to cleave the amide bond in the beta-lactam ring. This results in the formation of a stable, covalent acyl-enzyme intermediate, which effectively inactivates the enzyme and halts cell wall cross-linking.

Question 15

An experiment is designed to study peptidoglycan synthesis in Escherichia coli. A radiolabeled precursor, UDP-N-acetylmuramic acid (UDP-NAM), is added to a growing culture. After treatment with an unknown antibiotic, analysis reveals a significant accumulation of radiolabeled UDP-NAM-pentapeptide exclusively within the cytoplasm.

The accumulation of this specific intermediate suggests the antibiotic is most likely which of the following?

  1. Penicillin G
  2. Fosfomycin
  3. Vancomycin
  4. Bacitracin (correct answer)
Explanation: The accumulation of the completed cytoplasmic precursor, UDP-NAM-pentapeptide, indicates that its synthesis is intact but its transport to the periplasm is blocked. This transport requires the lipid carrier bactoprenol phosphate. Bacitracin inhibits the dephosphorylation of bactoprenol pyrophosphate back to bactoprenol phosphate, thus trapping the carrier in an unusable form and preventing the transport of new precursors. Penicillin and vancomycin act extracellularly. Fosfomycin acts in the cytoplasm but at a much earlier step (inhibiting MurA), which would prevent the formation of UDP-NAM-pentapeptide itself.

Question 16

The efficacy of the beta-lactam antibiotic class relies on the strained beta-lactam ring, which functions as a structural mimic of a key component in the cell wall synthesis pathway. This mimicry allows the antibiotic to bind and inactivate transpeptidases. What component is being mimicked?

  1. The N-acetylmuramic acid sugar moiety
  2. The bactoprenol phosphate lipid carrier
  3. The D-alanyl-D-alanine peptide terminus (correct answer)
  4. The pentaglycine interpeptide bridge
Explanation: The beta-lactam ring is a structural analog of the D-alanyl-D-alanine terminus of the peptidoglycan pentapeptide. The transpeptidase (penicillin-binding protein) active site recognizes this structure and attempts to cleave the amide bond in the beta-lactam ring. This results in the formation of a stable, covalent acyl-enzyme intermediate, which effectively inactivates the enzyme and halts cell wall cross-linking.

Question 17

A patient with atypical pneumonia caused by Mycoplasma pneumoniae is not responding to treatment with ceftriaxone. What is the fundamental microbiological basis for the ineffectiveness of ceftriaxone against this organism?

  1. The organism lacks a peptidoglycan cell wall. (correct answer)
  2. The organism rapidly effluxes the antibiotic across its cell membrane.
  3. The organism possesses penicillin-binding proteins with very low affinity for cephalosporins.
  4. The organism produces a chromosomal beta-lactamase that hydrolyzes ceftriaxone.
Explanation: Mycoplasma species are intrinsically resistant to all cell wall synthesis inhibitors, including beta-lactams like ceftriaxone, because they do not have a peptidoglycan cell wall. The drug's target is absent in the organism. The other options describe valid resistance mechanisms in other bacteria but are not the reason for the intrinsic resistance of Mycoplasma.

Question 18

An infection is caused by an Escherichia coli strain confirmed to produce an extended-spectrum beta-lactamase (ESBL), rendering it resistant to third-generation cephalosporins. However, the isolate remains susceptible to meropenem.

Which property of meropenem is the primary reason for its stability and continued activity against this ESBL-producing strain?

  1. A molecular structure that is highly resistant to hydrolysis by the ESBL enzyme. (correct answer)
  2. An ability to enter the periplasm through alternative outer membrane porins not used by cephalosporins.
  3. A mechanism of action that involves inhibiting beta-lactamase synthesis at the ribosomal level.
  4. A unique binding profile to a set of penicillin-binding proteins that are not targeted by cephalosporins.
Explanation: Carbapenems, such as meropenem, possess a unique stereochemical configuration at position C6 (a trans-hydroxyethyl group instead of an acylamino side chain) that confers significant resistance to hydrolysis by many beta-lactamases, including ESBLs. While binding profiles and porin entry are relevant to their overall activity, their stability in the face of these enzymes is the key reason for their effectiveness when other beta-lactams fail.

Question 19

Cycloserine is a second-line antitubercular agent that acts as a structural analog of D-alanine. Its bacteriostatic effect results from the competitive inhibition of which pair of enzymes crucial for peptidoglycan synthesis?

  1. Transpeptidase and transglycosylase
  2. InhA and KasA
  3. Alanine racemase and D-alanyl-D-alanine synthetase (correct answer)
  4. MurA and MurB transferases
Explanation: Cycloserine mimics the structure of D-alanine. It competitively inhibits two essential cytoplasmic enzymes: alanine racemase, which converts L-alanine to D-alanine, and D-alanyl-D-alanine synthetase (or ligase), which joins two D-alanine molecules to form the dipeptide needed for the pentapeptide chain. This starves the cell of the necessary D-Ala-D-Ala precursor. InhA and KasA are involved in mycolic acid synthesis (isoniazid targets). Transpeptidase and transglycosylase are later, periplasmic targets. MurA/B are earlier cytoplasmic steps not involving D-alanine.

Question 20

Isoniazid is a prodrug that, once activated by the mycobacterial catalase-peroxidase enzyme KatG, is a potent inhibitor of Mycobacterium tuberculosis cell wall synthesis. The activated form of isoniazid covalently binds to and inactivates an enzyme essential for the synthesis of which specific cell wall component?

  1. Arabinogalactan
  2. Peptidoglycan
  3. Lipoarabinomannan
  4. Mycolic acids (correct answer)
Explanation: Activated isoniazid's primary target is the enoyl-acyl carrier protein reductase, known as InhA. This enzyme is a critical component of the fatty acid synthase II (FAS-II) system, which is responsible for synthesizing the very long (C60-C90) mycolic acids that form the protective, waxy outer layer of the mycobacterial cell envelope. Arabinogalactan is the target of ethambutol.